This compensated study is for individuals ages 18-65, who regularly use Kratom, 7-OH, or
other opioids, and are interested in participating in research on long-acting injectable
naltrexone injections (Vivitrol®).
This study will test if adding an additional medication called buprenorphine-naloxone will
help people stay on long-acting naltrexone injections.
Participants starting treatment with Vivitrol® will be randomly assigned to receive
additional buprenorphine or placebo tablets. Random means by chance, it’s like flipping a
coin.
You will be monitored over 24 weeks (6 months).
This includes:
- Receiving injectable naltrexone (Vivitrol®) every 4 weeks. Vivitrol can be provided at no
cost through the study for qualifying participants.
- Weekly sessions with a medical clinician and research (medical check-in, vital sign
check, and urine drug screening). Transportation can be provided for participants via Uber
Health.
Compensation will be provided after each study visit. The maximum amount earned over
the 24 weeks for attending all study visits will be $770.
Please call or text 240-739-0626 for more information